Variables | Sugammadex (n = 39) | Neostigmine (n = 38) | P-value |  |
---|---|---|---|---|
Age (yr) | 72 (68–75) | 69 (67.75–74) | 0.256 |  |
Sex | Â | Â | 0.731 | Â |
 Male | 20 | 18 |  |  |
 Female | 19 | 20 |  |  |
BMI (kg/m2) | 23.53 (4.29) | 23.70(3.24) | 0.109 | Â |
ASA physical status | Â | Â | 0.429 | Â |
 I | 0 | 0 |  |  |
 II | 14 | 17 |  |  |
 III | 25 | 21 |  |  |
Preoperative medical history | ||||
 Hypertension | 15 | 12 | 0.527 |  |
 Diabetes mellitus | 3 | 0 | 0.081 |  |
 Cerebrovascular accident | 8 | 6 | 0.591 |  |
 Cerebral infarction | 7 | 2 | 0.083 |  |
Active tobacco | 15 | 18 | 0.430 | Â |
Preoperative anxiety scores | 3 (2–3) | 3(2–3) | 0.117 |  |
Surgery characteristics | ||||
 Surgery duration | 118 (110–126) | 116 (109.5–125) | 0.713 |  |
 One-lung ventilation duration | 100 (93–103) | 96.5 (91.5–106) | 0.510 |  |
 Anesthesia duration | 137 (128–140) | 135 (126.75–138.25) | 0.196 |  |
Nodule characteristics | Â | Â | 0.237 | Â |
 Malignant | 33 | 28 |  |  |
 Benign | 6 | 10 |  |  |
Lobectomy locations | Â | Â | 0.605 | Â |
 Left upper lobe | 7 | 12 | 0.165 |  |
 Left lower lobe | 4 | 5 | 0.692 |  |
 Right upper lobe | 15 | 11 | 0.377 |  |
 Right middle lobe | 5 | 5 | 0.965 |  |
 Right lower lobe | 8 | 5 | 0.389 |  |